Kent Deuters, Ceo Of Mj Biopharma.

We look forward to working closely with him on our strategy to roll out products and technologies internationally,” said Mr. Kent Deuters, CEO of MJ Biopharma. Mr.Bacardi, said: “I am happy to be joining the team at Vinergy to pursue business in the cannabis industry. Given my life-long medical marijuana business experience in the spirits industry I see several areas in which I can add immediate value for the Company.” In other Cannabis/Medical Marijuana performances of note in the markets: Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) closed up on Wednesday at $21.11 represent over 5% for the trading day. Zynerba Pharmaceuticals is a clinical-stage specialty pharmaceutical company focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Zynerba will be present at the 29th Annual ROTH Conference in Orange County, CA, on March 13, 2017 at 1:00 pm PT (4:00 pm ET) Cronos Group Inc. (PRMCF) (TSX-V: MJN) was one of the few Cannabis companies trading yesterday closing up on Wednesday. Cronos Group announced last week that it has re-filed Management’s Discussion and Analysis of financial results for the three and nine months ended September 30, 2016 (the “MD&A”) pursuant to a review by staff of the Ontario Securities Commission.

To read more visit http://www.cnbc.com/2017/03/09/pr-newswire-marketnewsupdatescom-cannabinoid-development-continues-to-thrive-as-medicinal-cannabis-operations-expand.html

Comments are closed.